Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01798693
Other study ID # ORB-12-2374
Secondary ID
Status Terminated
Phase Phase 0
First received January 18, 2013
Last updated May 11, 2015
Start date August 2013
Est. completion date August 2014

Study information

Verified date May 2015
Source University of North Carolina, Chapel Hill
Contact n/a
Is FDA regulated No
Health authority University of North Carolina: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Rotator Injury:

- Strength/range of Motion

- ASES, VAS


Description:

The addition of a nutritional therapy to a standardized physical therapy program, may expedite recovery from shoulder injury. An attractive feature of this approach is the development of an efficacious adjunct therapy that is economically superior to traditional therapy modalities and logistically feasible.


Recruitment information / eligibility

Status Terminated
Enrollment 5
Est. completion date August 2014
Est. primary completion date August 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Between 18-65 years old

- Diagnosed with rotator cuff injury that will not be treated surgically

Exclusion Criteria:

- Have received a previous injection therapy (platelet-rich plasma or corticosteroid injection) within previous 6 months

- Have used the following supplements in the previous 2 weeks: Vitamin C or D, or protein supplements

- Have poorly controlled type I or type II diabetes (HgB A1C > 9.5%) or renal insufficiency (GFR < 60 ml/min).

- Have an inability to participate in rehabilitation exercises.

- Are diagnosed with arthritis, rheumatoid arthritis, or any other autoimmune or rheumatologic disease

- Have musculoskeletal pathology in a neighboring joint or structure

- Have an allergy to any component of the nutritional supplement

- Are consuming warfarin

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Rotator Cuff/Shoulder Structure and Function

Intervention

Dietary Supplement:
Placebo (maltodextrin)

Multi-nutrient Blend


Locations

Country Name City State
United States UNC Orthopedics and Exercise and Sport Medicine Chapel Hill North Carolina

Sponsors (1)

Lead Sponsor Collaborator
University of North Carolina, Chapel Hill

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in shoulder function, pain, strength and range of motion Change from baseline to four, six, and twelve weeks No